Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase

Blerina Kola, Erika Hubina, Sonia A. Tucci, Tim C. Kirkham, Edwin A. Garcia, Sharon E. Mitchell, Lynda M. Williams, Simon A. Hawley, D. Grahame Hardie, Ashley B. Grossman, Márta Korbonits
2005 Journal of Biological Chemistry  
Endocannabinoids and ghrelin are potent appetite stimulators and are known to interact at a hypothalamic level. However, both also have important peripheral actions, including beneficial effects on the ischemic heart and increasing adipose tissue deposition, while ghrelin has direct effects on carbohydrate metabolism. The AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that functions as a fuel sensor to regulate energy balance at both cellular and whole body levels, and it may
more » ... iate the action of anti-diabetic drugs such as metformin and peroxisome proliferator-activated receptor ␥ agonists. Here we show that both cannabinoids and ghrelin stimulate AMPK activity in the hypothalamus and the heart, while inhibiting AMPK in liver and adipose tissue. These novel effects of cannabinoids on AMPK provide a mechanism for a number of their known actions, such as the reduction in infarct size in the myocardium, an increase in adipose tissue, and stimulation of appetite. The beneficial effects of ghrelin on heart function, including reduction of myocyte apoptosis, and its effects on lipogenesis and carbohydrate metabolism, can also be explained by its ability to activate AMPK. Our data demonstrate that AMPK not only links the orexigenic effects of endocannabinoids and ghrelin in the hypothalamus but also their effects on the metabolism of peripheral tissues.
doi:10.1074/jbc.c500175200 pmid:15899896 fatcat:q32dmogv6bcuvdsgptnp2qn4ga